Join Ms. Magazine and Get Our Landmark FEMINIST 250 Print Issue for This Pivotal Moment in American History

PUBLISHED 6/16/2026 by

As the U.S. prepares to mark its 250th birthday on July 4, 2026, questions loom over the celebration: Whose America gets remembered, whose gets erased—and how do we imagine and build a democracy that includes all of us? 

In the Summer issue of Ms., we revisit the nation’s founding through a feminist lens, reclaiming the stories too often left out of the official narrative: women who challenged the authors of the Declaration of Independence and later the U.S. Constitution for deliberately writing women out of America’s founding documents, Black women who resisted oppression from the start, Indigenous societies built around women-led governance, queer lives in revolutionary America, Asian women’s struggles for belonging and the long fight to make disability visible in our history.

We also look back at 54 years of feminist reporting from the pages of Ms.—proof that the battles for bodily autonomy, equality and democracy did not begin yesterday—and forward to the bold new ideas that could shape a freer, fairer future for the next 250 years.

Get a year of Ms. for just $20 (a 43 percent discount off our usual price) when you join today!

May 21 Virtual Event: Tackling Patriarchy and Power (With Anna Malaika Tubbs, Aisha Becker-Burrowes and Danielle Robay)

PUBLISHED 5/20/2026 by

The Feminist Majority Foundation and Ms. have partnered with Women’s Foundation California to invite you to a national virtual conversation with Dr. Anna Malaika Tubbs that turns our attention toward the system that has kept us from achieving true democracy for the last 250 years: patriarchy. 

Drawing from her latest book (and New York Times best-seller) Erased: What American Patriarchy Has Hidden from Us, Tubbs traces the ruthless logic that has organized American life for 250 years—always bound to race, always rooted in a binary that decides who counts and who does not.

The event is Thursday, May 21, 2026 at 5:30 p.m. PT / 7:30 CT / 8:30 ET. RSVP today!

Tubbs will be joined in conversation by Aisha Becker-Burrowes, co-founder and co-executive director of FEMINIST—a nonprofit media company serving a global community of over 6 million—and interviewed by TV host, journalist and content creator, Danielle Robay.

Black Feminist Visionary Beverly Guy-Sheftall to Discuss New Book ‘Black! Feminist! Free!’ @ LA Ms. Mag HQ, April 23

PUBLISHED 4/14/2026 by

A leading voice in Black feminist scholarship will take center stage in Beverly Hills later this month, as Beverly Guy-Sheftall joins professor and dean emerita Bonnie Thornton Dill for a public conversation on her new book, Black! Feminist! Free!

The event, hosted at Ms. magazine headquarters in Los Angeles on Thursday, April 23, from 6 to 8 p.m., is free and open to the public. Attendees can expect an evening of reflection, dialogue and community, with light refreshments provided. Copies of Guy-Sheftall’s book will be available for purchase on site, followed by a signing hosted by Reparations Club. RSVP today!

Symptoms, Hormones and the Fight for Better Care: What Every Woman Should Know About Menopause and Perimenopause

PUBLISHED 4/7/2026 by | UPDATED 4/14/2026 at 10:54 A.M. PT

When it comes to the menopause and perimenopause landscape, many women are left navigating symptoms without clear, trustworthy information.

This conversation aims to change that—offering evidence-based insights, practical guidance and a broader look at the systemic reforms needed to improve menopause care.

Cover Reveal and Spring 2026 Issue Sneak Peek: ICE Is ‘the Army of the Patriarchy’

PUBLISHED 3/17/2026 by

In early February, while the nation was still reeling from the murders of Renee Good and Alex Pretti by federal agents, Loretta Ross and Jackson Katz—two feminist academics with decidedly different backgrounds and identities—discussed how U.S. federal agents became the enforcement arm of the nation’s racism and misogyny.

You’ll find this, and more, in the Spring 2026 issue of Ms.

Look for Ms. Magazine at Hudson News This Women’s History Month

PUBLISHED 3/13/2026 by

Traveling this month? Keep your eyes peeled. For Women’s History Month, Ms. magazine is hitting the shelves at Hudson News airport bookstores across the country.

If you spot Ms. at Hudson News, snap a photo and tag @msmagazine on social media—we’d love to see it. Consider grabbing a copy for your flight; every purchase helps sustain our feminist journalism.

Who Controls Mifepristone? The Politics Blocking a New Era of Contraception

PUBLISHED 1/22/2026 by

Mifepristone “works against endometriosis. It works against myoma [fibroids]. We are now involved in a study group that looks at whether it can prevent breast cancer,” says pioneering reproductive-health advocate Dr. Rebecca Gomperts. “It has so many potential uses, and it hasn’t been [developed].

“If we as women don’t make sure that it becomes available to meet our needs … then it won’t happen.”

This is the final installment of a new series, “The Moral Property of Women: How Antiabortion Politics Are Withholding Medical Care,” a serialized version of the Winter 2026 print feature article.

Mifepristone Could Treat Endometriosis, Some Cancers, Depression and Chronic Illness—If Politics Didn’t Interfere

PUBLISHED 1/21/2026 by

Across a range of conditions that disproportionately affect women, research into mifepristone’s potential has been slowed, defunded or blocked altogether. Nowhere is that clearer than in the treatment of endometriosis and other serious illnesses that leave millions of women in chronic pain.

Endometriosis—when endometrium cells grow outside the uterus—afflicts an estimated 10 percent of reproductive-age women. It can lead to chronic pelvic and back pain, heavy or abnormal bleeding, pain during sex or bowel movements, fatigue, bloating, digestive issues, infertility, anxiety and depression.

Mifepristone can help—it blocks the progesterone causing the cellular growth and decreases the size of existing endometrial lesions, thereby relieving painful symptoms. But antiabortion politics have obstructed the development of the medication for these uses in the U.S.

Researchers have also produced studies showing mifepristone is effective for treating ovarian and breast cancer, chronic inflammatory diseases, and several psychiatric disorders, including major depressive disorder, post-traumatic stress disorder (PTSD) and psychotic depression.

This is Part 2 of 3 in a new series, “The Moral Property of Women: How Antiabortion Politics Are Withholding Medical Care,” a serialized version of the Winter 2026 print feature article.

‘The Moral Property of Women’: Mifepristone, Fibroids and the Stakes of Suppressed Science

PUBLISHED 1/20/2026 by

Despite mifepristone’s broad medical promise, its development has been repeatedly stymied by abortion opponents who fear wider availability would weaken their attempts to suppress abortion access.

More than 26 million women in the U.S. are affected by fibroids, which are noncancerous growths of the uterus that can reach the size of a grapefruit or larger. Treatment too often defaults to invasive surgery, either removing the fibroids or performing hysterectomies.

In China today, a three-month regimen of 10 milligrams of mifepristone per day is the approved protocol for treating fibroids. Meanwhile, American women still do not have access to this very effective nonsurgical treatment.

This is Part 1 of 3 in a new series, “The Moral Property of Women: How Antiabortion Politics Are Withholding Medical Care,” a serialized version of the Winter 2026 print feature article.